Microdose study of a P-glycoprotein substrate, fexofenadine, using a non-radioisotope-labelled drug and LC/MS/MS.
about
Quantification of fexofenadine in biological matrices: a review of bioanalytical methods.Dose selection method for pharmacokinetic study in hemodialysis patients using a subpharmacological dose: oseltamivir as a model drug.Microdosing and drug development: past, present and futurePharmacokinetic studies in infants using minimal-risk study designsThe application of human phase 0 microdosing trials: A systematic review and perspectives.The Prediction of the Relative Importance of CYP3A/P-glycoprotein to the Nonlinear Intestinal Absorption of Drugs by Advanced Compartmental Absorption and Transit Model.Microdose study of 14C-acetaminophen with accelerator mass spectrometry to examine pharmacokinetics of parent drug and metabolites in healthy subjects.High-sensitive LC-MS/MS method for the simultaneous determination of mirodenafil and its major metabolite, SK-3541, in human plasma: application to microdose clinical trials of mirodenafil.A nanogram dose of the CYP3A probe substrate midazolam to evaluate drug interactions.Dose-dependent exposure and metabolism of GNE-892, a β-secretase inhibitor, in monkeys: contributions by P450, AO, and P-gp.
P2860
Q34166009-0E53D180-F84A-4C00-A277-E2A9F9B1731DQ35122440-38874B36-97F9-426B-8E45-8CD7E9821BDDQ35940544-BBAC52DC-80C3-4ADF-A01D-179B7E5024E7Q36438116-C739B22F-E3B6-4B13-B20E-C7B68BBE6FA8Q38597205-0C643143-793D-4490-BB83-1A94ABD1479AQ39476375-FC493AF5-A88F-448B-9BDE-3BF30D071B66Q42837250-0D00773E-F422-45F8-BA22-37871A162AC2Q46425275-2F8D9273-AF4A-40D3-86BF-30CC6D195D87Q48025123-400A3133-D355-4C2E-887D-6255818159DAQ51744154-5694BC15-7AB2-492D-B8A1-7FA5D8C42E02
P2860
Microdose study of a P-glycoprotein substrate, fexofenadine, using a non-radioisotope-labelled drug and LC/MS/MS.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Microdose study of a P-glycopr ...... pe-labelled drug and LC/MS/MS.
@en
Microdose study of a P-glycopr ...... pe-labelled drug and LC/MS/MS.
@nl
type
label
Microdose study of a P-glycopr ...... pe-labelled drug and LC/MS/MS.
@en
Microdose study of a P-glycopr ...... pe-labelled drug and LC/MS/MS.
@nl
prefLabel
Microdose study of a P-glycopr ...... pe-labelled drug and LC/MS/MS.
@en
Microdose study of a P-glycopr ...... pe-labelled drug and LC/MS/MS.
@nl
P2093
P2860
P1476
Microdose study of a P-glycopr ...... pe-labelled drug and LC/MS/MS.
@en
P2093
A Yamazaki
Y Sugiyama
P2860
P304
P356
10.1111/J.1365-2710.2009.01159.X
P577
2010-04-01T00:00:00Z